These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27456062)

  • 21. Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs.
    Geib T; Hertel KJ
    PLoS One; 2009 Dec; 4(12):e8204. PubMed ID: 19997596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes.
    Marquis J; Kämpfer SS; Angehrn L; Schümperli D
    Gene Ther; 2009 Jan; 16(1):70-7. PubMed ID: 18701908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals.
    Sahashi K; Hua Y; Ling KK; Hung G; Rigo F; Horev G; Katsuno M; Sobue G; Ko CP; Bennett CF; Krainer AR
    Genes Dev; 2012 Aug; 26(16):1874-84. PubMed ID: 22895255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutics that directly increase SMN expression to treat spinal muscular atrophy.
    Shababi M; Mattis VB; Lorson CL
    Drug News Perspect; 2010 Oct; 23(8):475-82. PubMed ID: 21031163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene.
    Seo J; Singh NN; Ottesen EW; Sivanesan S; Shishimorova M; Singh RN
    PLoS One; 2016; 11(4):e0154390. PubMed ID: 27111068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy.
    Naryshkin NA; Weetall M; Dakka A; Narasimhan J; Zhao X; Feng Z; Ling KK; Karp GM; Qi H; Woll MG; Chen G; Zhang N; Gabbeta V; Vazirani P; Bhattacharyya A; Furia B; Risher N; Sheedy J; Kong R; Ma J; Turpoff A; Lee CS; Zhang X; Moon YC; Trifillis P; Welch EM; Colacino JM; Babiak J; Almstead NG; Peltz SW; Eng LA; Chen KS; Mull JL; Lynes MS; Rubin LL; Fontoura P; Santarelli L; Haehnke D; McCarthy KD; Schmucki R; Ebeling M; Sivaramakrishnan M; Ko CP; Paushkin SV; Ratni H; Gerlach I; Ghosh A; Metzger F
    Science; 2014 Aug; 345(6197):688-93. PubMed ID: 25104390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.
    Rashnonejad A; Amini Chermahini G; Gündüz C; Onay H; Aykut A; Durmaz B; Baka M; Su Q; Gao G; Özkınay F
    Mol Ther; 2019 Dec; 27(12):2123-2133. PubMed ID: 31543414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models.
    Osman EY; Miller MR; Robbins KL; Lombardi AM; Atkinson AK; Brehm AJ; Lorson CL
    Hum Mol Genet; 2014 Sep; 23(18):4832-45. PubMed ID: 24781211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
    See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C
    Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
    Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL
    Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HnRNP C1/C2 may regulate exon 7 splicing in the spinal muscular atrophy gene SMN1.
    Irimura S; Kitamura K; Kato N; Saiki K; Takeuchi A; Gunadi ; Matsuo M; Nishio H; Lee MJ
    Kobe J Med Sci; 2009 Mar; 54(5):E227-36. PubMed ID: 19628962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal muscular atrophy: state-of-the-art and therapeutic perspectives.
    Wirth B
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):87-95. PubMed ID: 12215230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.
    Kashima T; Manley JL
    Nat Genet; 2003 Aug; 34(4):460-3. PubMed ID: 12833158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease mechanisms and therapeutic approaches in spinal muscular atrophy.
    Tisdale S; Pellizzoni L
    J Neurosci; 2015 Jun; 35(23):8691-700. PubMed ID: 26063904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
    d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
    Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy.
    Harris AW; Butchbach ME
    Neuromuscul Disord; 2015 Sep; 25(9):699-705. PubMed ID: 26055638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing.
    Coady TH; Shababi M; Tullis GE; Lorson CL
    Mol Ther; 2007 Aug; 15(8):1471-8. PubMed ID: 17551501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense genes to induce exon inclusion.
    Nlend RN; Schümperli D
    Methods Mol Biol; 2012; 867():325-47. PubMed ID: 22454071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression level of Tra2-β1 is responsible for increased SMN2 exon 7 inclusion in the testis of SMA mice.
    Chen YC; Chang JG; Jong YJ; Liu TY; Yuo CY
    PLoS One; 2015; 10(3):e0120721. PubMed ID: 25781985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.